Article(id=1329832446293553257, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329832316572119996, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.09.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1676304000000, receivedDateStr=2023-02-14, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794986362288, onlineDateStr=2026-11-18, pubDate=1694275200000, pubDateStr=2023-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794986362288, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794986362288, creator=13701087609, updateTime=1794986362288, updator=13701087609, issue=Issue{id=1329832316572119996, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='9', pageStart='895', pageEnd='1016', issueExtLink='null', onlineDate='null', pubDate='1694275200000', pubDateStr='2023-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794986331360, creator='13701087609', updateTime=1794988494433, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329841389711503745, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329832316572119996, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329841389715698050, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329832316572119996, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=981, endPage=989, ext={EN=ArticleExt(id=1329832446595543146, articleId=1329832446293553257, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Cost-effectiveness analysis of nintedanib esylate in the treatment of idiopathic pulmonary fibrosis, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To evaluate the cost-effectiveness analysis of nintedanib esylate in the treatment of idiopathic pulmonary fibrosis (IPF).

Methods

From the perspective of Chinese healthcare system, a Markov model was constructed to evaluate the cost-effectiveness of nintedanib esylate compared with pirfenidone in the treatment of IPF patients. The model cycle was one month using a lifetime horizon. The discount rate of both cost and effectiveness was 5%. One-way sensitivity analysis, probabilistic sensitivity analysis and scenario analysis were used to verify the robustness of the base case results.

Results

The results of the base case showed that compared with generic pirfenidone, nintedanib esylate had lower costs and higher quality-adjusted life years output in the treatment of IPF patients, which had absolute advantages and was a more economical program. The conclusion was verified in one-way sensitivity analysis, probabilistic sensitivity analysis and scenario analysis.

Conclusion

Nintedanib esylate is a cost-effective alternative compared with generic pirfenidone in Chinese patients with IPF.

, authors=Jiahao HU1, Yuhan LIU1, Xingming PAN2, Chunlin JIN1, Fen LI1, *, authorsList=Jiahao HU, Yuhan LIU, Xingming PAN, Chunlin JIN, Fen LI, authorCompany=null, correspAuthors=Fen LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329832446876561515, articleId=1329832446293553257, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=乙磺酸尼达尼布用于特发性肺纤维化治疗的成本-效果分析, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

评估乙磺酸尼达尼布对特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)患者的经济性。

方法

从中国卫生体系角度构建马尔科夫模型,评价乙磺酸尼达尼布对比国产吡非尼酮治疗IPF成人患者的经济性。模型周期为1个月,模拟时限为终身,成本和效果贴现率为5%。采用单因素敏感性分析、概率敏感性分析及情境分析验证基础分析结果的稳健性。

结果

基础分析结果表明,与国产吡非尼酮相比,乙磺酸尼达尼布治疗IPF成本更低,质量调整生命年产出更高,具有绝对优势,更具有经济性,且该结论在单因素敏感性分析、概率敏感性分析及情境分析中均被验证稳健性。

结论

对于IPF患者,与使用国产吡非尼酮相比,乙磺酸尼达尼布是更具经济性的方案。

, authors=胡嘉浩1, 刘宇晗1, 潘星明2, 金春林1, 李芬1, *, authorsList=胡嘉浩, 刘宇晗, 潘星明, 金春林, 李芬, authorCompany=null, correspAuthors=李芬, authorNote=

胡嘉浩,研究实习员,研究方向:药物经济学、药品政策。

, correspAuthorsNote=
李芬,副研究员,研究方向:卫生经济学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=5PDCkM1hGvkrpK7ZOl+tkQ==, magXml=y80SIs+Rh49HK27IVo95TQ==, pdfUrl=null, pdf=NLRUMBQiBFiUDe3loDbzVg==, pdfFileSize=2072986, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=+nk2qi/VGvRBZa3Gk/iFgg==, mapNumber=null, fund=null)}, authors=[Author(id=1329832447316963443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832447430209653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447316963443, language=EN, stringName=Jiahao HU, firstName=Jiahao, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832447497318518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447316963443, language=CN, stringName=胡嘉浩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040, bio={"content":"

胡嘉浩,研究实习员,研究方向:药物经济学、药品政策。

"}, bioImg=null, bioContent=

胡嘉浩,研究实习员,研究方向:药物经济学、药品政策。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)])]), Author(id=1329832447572815992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832447656702074, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447572815992, language=EN, stringName=Yuhan LIU, firstName=Yuhan, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832447711228027, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447572815992, language=CN, stringName=刘宇晗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)])]), Author(id=1329832447778336893, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832447858028671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447778336893, language=EN, stringName=Xingming PAN, firstName=Xingming, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.International School of Pharmaceutical Business, China Pharmaceutical University, Nanjing 210009, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832447920943232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447778336893, language=CN, stringName=潘星明, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国药科大学国际医药商学院,江苏 南京 210009, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447216300143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=2., ext=[AuthorCompanyExt(id=1329832447224688752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447216300143, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.International School of Pharmaceutical Business, China Pharmaceutical University, Nanjing 210009, Jiangsu Province, China), AuthorCompanyExt(id=1329832447233077361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447216300143, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学国际医药商学院,江苏 南京 210009)])]), Author(id=1329832448004829314, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832449657385092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832448004829314, language=EN, stringName=Chunlin JIN, firstName=Chunlin, middleName=null, lastName=JIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832449753854085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832448004829314, language=CN, stringName=金春林, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)])]), Author(id=1329832449825157255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329832449946792073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832449825157255, language=EN, stringName=Fen LI, firstName=Fen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832450034872458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832449825157255, language=CN, stringName=李芬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)])])], keywords=[Keyword(id=1329832450202644619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, language=EN, orderNo=1, keyword=nintedanib esylate), Keyword(id=1329832450353639564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, language=EN, orderNo=2, keyword=idiopathic pulmonary fibrosis), Keyword(id=1329832450684989581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, language=EN, orderNo=3, keyword=cost-effectiveness analysis), Keyword(id=1329832450823401614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, language=EN, orderNo=4, keyword=pirfenidone), Keyword(id=1329832450886316175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, language=CN, orderNo=1, keyword=乙磺酸尼达尼布), Keyword(id=1329832450970202256, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, language=CN, orderNo=2, keyword=特发性肺纤维化), Keyword(id=1329832451037311121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, language=CN, orderNo=3, keyword=成本-效果分析), Keyword(id=1329832451087642770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, language=CN, orderNo=4, keyword=吡非尼酮)], refs=[Reference(id=1329832451171528851, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=叶俏, 代华平. 特发性肺纤维化诊断和治疗中国专家共识[J]. 中华结核和呼吸杂志, 2016, 39(6): 427-432., articleTitle=null, refAbstract=null), Reference(id=1329832451242832020, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=国家卫生健康委员会, 科学技术部, 工业信息化部, 等. 关于公布第一批罕见病目录的通知[EB/OL]. (2018-12-31) [2022-12-20]. http://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5435167.htm., articleTitle=null, refAbstract=null), Reference(id=1329832451343495317, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Maher TM, Bendstrup E, Dron L, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis[J]. Respir Res, 2021, 22(1): 197., articleTitle=null, refAbstract=null), Reference(id=1329832451423187094, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Kreuter M, Wuyts WA, Wijsenbeek M, et al. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS(R) trials[J]. Respir Res, 2020, 21(1): 36., articleTitle=null, refAbstract=null), Reference(id=1329832451553210519, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Cai M, Zhu M, Ban C, et al. Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis[J]. Chin Med J (Engl), 2014, 127(10): 1868-1873., articleTitle=null, refAbstract=null), Reference(id=1329832451632902296, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2007, 176(7): 636-643., articleTitle=null, refAbstract=null), Reference(id=1329832451712594073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome[J]. Eur Respir J, 2011, 37(2): 356-363., articleTitle=null, refAbstract=null), Reference(id=1329832451783897242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Yount SE, Beaumont JL, Chen SY, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis[J]. Lung, 2016, 194(2): 227-234., articleTitle=null, refAbstract=null), Reference(id=1329832451846811803, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=宣建伟, 卢永吉, 任懋东, 等. 中国特发性肺纤维化患者的直接经济负担[J]. 中国药物经济学, 2019, 14(6): 9-12., articleTitle=null, refAbstract=null), Reference(id=1329832451913920669, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline[J]. Am J Respir Crit Care Med, 2015, 192(2): e3-e19., articleTitle=null, refAbstract=null), Reference(id=1329832451993612446, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med, 2011, 183(6): 788-824., articleTitle=null, refAbstract=null), Reference(id=1329832452069109919, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=NICE. Nintedanib for treating idiopathic pulmonary fibrosis[EB/OL]. (2016-01-27) [2022-12-19]. https://www.nice.org.uk/guidance/ta379., articleTitle=null, refAbstract=null), Reference(id=1329832452136218784, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=NICE. Pirfenidone for treating idiopathic pulmonary fibrosis[EB/OL]. (2018-02-06) [2022-12-19]. https://www.nice.org.uk/guidance/ta504., articleTitle=null, refAbstract=null), Reference(id=1329832452203327649, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=姜秋燕, 梁庆, 高劭妍, 等. 特发性肺纤维化治疗药物研究进展[J]. 中国新药杂志, 2021, 30(14): 1274-1281., articleTitle=null, refAbstract=null), Reference(id=1329832452262047906, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=王春彬, 张爽, 张倩, 等. 两种新型抗纤维化药物治疗特发性肺纤维化的研究进展[J]. 中国药学杂志, 2019, 54(9): 682-686., articleTitle=null, refAbstract=null), Reference(id=1329832452316573859, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Rinciog C, Watkins M, Chang S, et al. A cost-effectiveness analysis of nintedanib in idiopathic pulmonary fibrosis in the UK[J]. Pharmacoeconomics, 2017, 35(4): 479-491., articleTitle=null, refAbstract=null), Reference(id=1329832452383682724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会. 常规肺功能检查基层指南(2018年)[J]. 中华全科医师杂志, 2019(6): 511-518., articleTitle=null, refAbstract=null), Reference(id=1329832452459180197, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=朱蕾, 陈荣昌. 成人常规肺功能测定规范中国专家共识[J]. 临床肺科杂志, 2022, 27(11): 1621-1633., articleTitle=null, refAbstract=null), Reference(id=1329832452522094758, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Dempsey TM, Thao V, Moriarty JP, et al. Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States[J]. Bio Med Central Pulm Med, 2022, 22(1): 18., articleTitle=null, refAbstract=null), Reference(id=1329832454120124583, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Clay E, Cristeau O, Chafaie R, et al. Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France[J]. J Mark Access Health Policy, 2019, 7(1): 1626171., articleTitle=null, refAbstract=null), Reference(id=1329832454183039144, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Loveman E, Copley VR, Colquitt J, et al. The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation[J]. Health Technol Assess, 2015, 19(20): 1-336., articleTitle=null, refAbstract=null), Reference(id=1329832454241759401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=刘国恩. 中国药物经济学评价指南2020[M]. 中国市场出版社, 2020: 26-28., articleTitle=null, refAbstract=null), Reference(id=1329832454338228394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials[J]. Lancet, 2011, 377(9779): 1760-1769., articleTitle=null, refAbstract=null), Reference(id=1329832454409531563, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014, 370(22): 2071-2082., articleTitle=null, refAbstract=null), Reference(id=1329832454485029036, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Ryerson CJ, Kolb M, Richeldi L, et al. Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage[J]. Eur Respir J Open Res, 2019, 5(2): 00127-2018., articleTitle=null, refAbstract=null), Reference(id=1329832454589886637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Qin S, Kruger E, Tan SC, et al. Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China[J]. Cost Eff Resour Alloc, 2018, 16: 29., articleTitle=null, refAbstract=null), Reference(id=1329832454661189806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Guan H, Liu G, Xie F, et al. Cost-effectiveness of osimertinib as a second-line treatment in patients with EGFR-mutated advanced non-small cell lung cancer in China[J]. Clin Ther, 2019, 41(11): 2308-2320., articleTitle=null, refAbstract=null), Reference(id=1329832454761853103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Hopkins RB, Burke N, Fell C, et al. Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada[J]. Eur Respir J, 2016, 48(1): 187-195., articleTitle=null, refAbstract=null), Reference(id=1329832454837350576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=曾昭全, 刘莹, 刘锡钧. 治疗功能性眩晕两种方案的药物经济学分析[J]. 海峡药学, 2002, 14(2): 52-53., articleTitle=null, refAbstract=null), Reference(id=1329832454908653745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Ara R, Brazier JE. Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available[J]. Value Health, 2011, 14(4): 539-545., articleTitle=null, refAbstract=null), Reference(id=1329832454971568306, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=马艺蕾, 伏振, 段彦然, 等. 吡非尼酮与尼达尼布治疗特发性肺纤维化的成本-效果分析[J]. 医药导报, 2020, 39(11): 1552-1557., articleTitle=null, refAbstract=null), Reference(id=1329832455055454387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu Z, Li H, Wen F, et al. Subgroup analysis for Chinese patients included in the INPULSIS® trials on nintedanib in idiopathic pulmonary fibrosis[J]. Adv Ther, 2019, 36(3): 621-631., articleTitle=null, refAbstract=null), Reference(id=1329832455126757556, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014, 370(22): 2071-2082., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)]), AuthorCompany(id=1329832447216300143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=2., ext=[AuthorCompanyExt(id=1329832447224688752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447216300143, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.International School of Pharmaceutical Business, China Pharmaceutical University, Nanjing 210009, Jiangsu Province, China), AuthorCompanyExt(id=1329832447233077361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447216300143, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学国际医药商学院,江苏 南京 210009)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.09.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.09.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.09.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.09.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1694275200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
乙磺酸尼达尼布用于特发性肺纤维化治疗的成本-效果分析
胡嘉浩 1 , 刘宇晗 1 , 潘星明 2 , 金春林 1 , 李芬 1, *
世界临床药物 | 研究论文 2023,44(9): 981-989
收起
收藏切换
世界临床药物 |研究论文 2023 , 44 (9) : 981 -989
乙磺酸尼达尼布用于特发性肺纤维化治疗的成本-效果分析
全屏
[Author(id=1329832447316963443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832447430209653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447316963443, language=EN, stringName=Jiahao HU, firstName=Jiahao, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832447497318518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447316963443, language=CN, stringName=胡嘉浩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040, bio={"content":"

胡嘉浩,研究实习员,研究方向:药物经济学、药品政策。

"}, bioImg=null, bioContent=

胡嘉浩,研究实习员,研究方向:药物经济学、药品政策。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)])]), Author(id=1329832447572815992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832447656702074, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447572815992, language=EN, stringName=Yuhan LIU, firstName=Yuhan, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832447711228027, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447572815992, language=CN, stringName=刘宇晗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)])]), Author(id=1329832447778336893, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832447858028671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447778336893, language=EN, stringName=Xingming PAN, firstName=Xingming, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.International School of Pharmaceutical Business, China Pharmaceutical University, Nanjing 210009, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832447920943232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832447778336893, language=CN, stringName=潘星明, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国药科大学国际医药商学院,江苏 南京 210009, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447216300143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=2., ext=[AuthorCompanyExt(id=1329832447224688752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447216300143, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.International School of Pharmaceutical Business, China Pharmaceutical University, Nanjing 210009, Jiangsu Province, China), AuthorCompanyExt(id=1329832447233077361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447216300143, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学国际医药商学院,江苏 南京 210009)])]), Author(id=1329832448004829314, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832449657385092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832448004829314, language=EN, stringName=Chunlin JIN, firstName=Chunlin, middleName=null, lastName=JIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832449753854085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832448004829314, language=CN, stringName=金春林, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)])]), Author(id=1329832449825157255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329832449946792073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832449825157255, language=EN, stringName=Fen LI, firstName=Fen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832450034872458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, authorId=1329832449825157255, language=CN, stringName=李芬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832447098859628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, xref=1., ext=[AuthorCompanyExt(id=1329832447107248237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China), AuthorCompanyExt(id=1329832447115636846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832446293553257, companyId=1329832447098859628, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040)])])]
胡嘉浩1, 刘宇晗1, 潘星明2, 金春林1, 李芬1, *
作者信息
  • 1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040
  • 2.中国药科大学国际医药商学院,江苏 南京 210009
通讯作者:
李芬,副研究员,研究方向:卫生经济学。
作者简介:

胡嘉浩,研究实习员,研究方向:药物经济学、药品政策。

Cost-effectiveness analysis of nintedanib esylate in the treatment of idiopathic pulmonary fibrosis
Jiahao HU1, Yuhan LIU1, Xingming PAN2, Chunlin JIN1, Fen LI1, *
Affiliations
  • 1.Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai 200040, China
  • 2.International School of Pharmaceutical Business, China Pharmaceutical University, Nanjing 210009, Jiangsu Province, China
出版时间: 2023-09-10 doi: 10.13683/j.wph.2023.09.015
文章导航
收藏切换
目的

评估乙磺酸尼达尼布对特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)患者的经济性。

方法

从中国卫生体系角度构建马尔科夫模型,评价乙磺酸尼达尼布对比国产吡非尼酮治疗IPF成人患者的经济性。模型周期为1个月,模拟时限为终身,成本和效果贴现率为5%。采用单因素敏感性分析、概率敏感性分析及情境分析验证基础分析结果的稳健性。

结果

基础分析结果表明,与国产吡非尼酮相比,乙磺酸尼达尼布治疗IPF成本更低,质量调整生命年产出更高,具有绝对优势,更具有经济性,且该结论在单因素敏感性分析、概率敏感性分析及情境分析中均被验证稳健性。

结论

对于IPF患者,与使用国产吡非尼酮相比,乙磺酸尼达尼布是更具经济性的方案。

乙磺酸尼达尼布  /  特发性肺纤维化  /  成本-效果分析  /  吡非尼酮
Objective

To evaluate the cost-effectiveness analysis of nintedanib esylate in the treatment of idiopathic pulmonary fibrosis (IPF).

Methods

From the perspective of Chinese healthcare system, a Markov model was constructed to evaluate the cost-effectiveness of nintedanib esylate compared with pirfenidone in the treatment of IPF patients. The model cycle was one month using a lifetime horizon. The discount rate of both cost and effectiveness was 5%. One-way sensitivity analysis, probabilistic sensitivity analysis and scenario analysis were used to verify the robustness of the base case results.

Results

The results of the base case showed that compared with generic pirfenidone, nintedanib esylate had lower costs and higher quality-adjusted life years output in the treatment of IPF patients, which had absolute advantages and was a more economical program. The conclusion was verified in one-way sensitivity analysis, probabilistic sensitivity analysis and scenario analysis.

Conclusion

Nintedanib esylate is a cost-effective alternative compared with generic pirfenidone in Chinese patients with IPF.

nintedanib esylate  /  idiopathic pulmonary fibrosis  /  cost-effectiveness analysis  /  pirfenidone
胡嘉浩, 刘宇晗, 潘星明, 金春林, 李芬. 乙磺酸尼达尼布用于特发性肺纤维化治疗的成本-效果分析. 世界临床药物, 2023 , 44 (9) : 981 -989 . DOI: 10.13683/j.wph.2023.09.015
Jiahao HU, Yuhan LIU, Xingming PAN, Chunlin JIN, Fen LI. Cost-effectiveness analysis of nintedanib esylate in the treatment of idiopathic pulmonary fibrosis[J]. World Clinical Drug, 2023 , 44 (9) : 981 -989 . DOI: 10.13683/j.wph.2023.09.015

参考文献 引证文献
排序方式:
[1]
叶俏, 代华平. 特发性肺纤维化诊断和治疗中国专家共识[J]. 中华结核和呼吸杂志, 2016, 39(6): 427-432.
[2]
国家卫生健康委员会, 科学技术部, 工业信息化部, 等. 关于公布第一批罕见病目录的通知[EB/OL]. (2018-12-31) [2022-12-20]. http://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5435167.htm.
[3]
Maher TM, Bendstrup E, Dron L, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis[J]. Respir Res, 2021, 22(1): 197.
[4]
Kreuter M, Wuyts WA, Wijsenbeek M, et al. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS(R) trials[J]. Respir Res, 2020, 21(1): 36.
[5]
Cai M, Zhu M, Ban C, et al. Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis[J]. Chin Med J (Engl), 2014, 127(10): 1868-1873.
[6]
Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2007, 176(7): 636-643.
[7]
Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome[J]. Eur Respir J, 2011, 37(2): 356-363.
[8]
Yount SE, Beaumont JL, Chen SY, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis[J]. Lung, 2016, 194(2): 227-234.
[9]
宣建伟, 卢永吉, 任懋东, 等. 中国特发性肺纤维化患者的直接经济负担[J]. 中国药物经济学, 2019, 14(6): 9-12.
[10]
Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline[J]. Am J Respir Crit Care Med, 2015, 192(2): e3-e19.
[11]
Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
[12]
NICE. Nintedanib for treating idiopathic pulmonary fibrosis[EB/OL]. (2016-01-27) [2022-12-19]. https://www.nice.org.uk/guidance/ta379.
[13]
NICE. Pirfenidone for treating idiopathic pulmonary fibrosis[EB/OL]. (2018-02-06) [2022-12-19]. https://www.nice.org.uk/guidance/ta504.
[14]
姜秋燕, 梁庆, 高劭妍, 等. 特发性肺纤维化治疗药物研究进展[J]. 中国新药杂志, 2021, 30(14): 1274-1281.
[15]
王春彬, 张爽, 张倩, 等. 两种新型抗纤维化药物治疗特发性肺纤维化的研究进展[J]. 中国药学杂志, 2019, 54(9): 682-686.
[16]
Rinciog C, Watkins M, Chang S, et al. A cost-effectiveness analysis of nintedanib in idiopathic pulmonary fibrosis in the UK[J]. Pharmacoeconomics, 2017, 35(4): 479-491.
[17]
中华医学会. 常规肺功能检查基层指南(2018年)[J]. 中华全科医师杂志, 2019(6): 511-518.
[18]
朱蕾, 陈荣昌. 成人常规肺功能测定规范中国专家共识[J]. 临床肺科杂志, 2022, 27(11): 1621-1633.
[19]
Dempsey TM, Thao V, Moriarty JP, et al. Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States[J]. Bio Med Central Pulm Med, 2022, 22(1): 18.
[20]
Clay E, Cristeau O, Chafaie R, et al. Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France[J]. J Mark Access Health Policy, 2019, 7(1): 1626171.
[21]
Loveman E, Copley VR, Colquitt J, et al. The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation[J]. Health Technol Assess, 2015, 19(20): 1-336.
[22]
刘国恩. 中国药物经济学评价指南2020[M]. 中国市场出版社, 2020: 26-28.
[23]
Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials[J]. Lancet, 2011, 377(9779): 1760-1769.
[24]
Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014, 370(22): 2071-2082.
[25]
Ryerson CJ, Kolb M, Richeldi L, et al. Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage[J]. Eur Respir J Open Res, 2019, 5(2): 00127-2018.
[26]
Qin S, Kruger E, Tan SC, et al. Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China[J]. Cost Eff Resour Alloc, 2018, 16: 29.
[27]
Guan H, Liu G, Xie F, et al. Cost-effectiveness of osimertinib as a second-line treatment in patients with EGFR-mutated advanced non-small cell lung cancer in China[J]. Clin Ther, 2019, 41(11): 2308-2320.
[28]
Hopkins RB, Burke N, Fell C, et al. Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada[J]. Eur Respir J, 2016, 48(1): 187-195.
[29]
曾昭全, 刘莹, 刘锡钧. 治疗功能性眩晕两种方案的药物经济学分析[J]. 海峡药学, 2002, 14(2): 52-53.
[30]
Ara R, Brazier JE. Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available[J]. Value Health, 2011, 14(4): 539-545.
[31]
马艺蕾, 伏振, 段彦然, 等. 吡非尼酮与尼达尼布治疗特发性肺纤维化的成本-效果分析[J]. 医药导报, 2020, 39(11): 1552-1557.
[32]
Xu Z, Li H, Wen F, et al. Subgroup analysis for Chinese patients included in the INPULSIS® trials on nintedanib in idiopathic pulmonary fibrosis[J]. Adv Ther, 2019, 36(3): 621-631.
[33]
Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014, 370(22): 2071-2082.
2023年第44卷第9期
13
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.09.015
  • 接收时间:2023-02-14
  • 首发时间:2026-11-18
  • 出版时间:2023-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-02-14
基金
作者信息
    1.上海市卫生和健康发展研究中心(上海市医学科学情报技术研究所),上海 200040
    2.中国药科大学国际医药商学院,江苏 南京 210009

通讯作者:

李芬,副研究员,研究方向:卫生经济学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.09.015
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏